158 related articles for article (PubMed ID: 17588942)
21. In vitro modification of solid phase multiple antigenic peptides/autoantigens with 4-hydroxy-2-nonenal (HNE) provide ideal substrates for detection of anti-HNE antibodies and peptide antioxidants.
Kurien BT; Scofield RH
J Immunol Methods; 2005 Aug; 303(1-2):66-75. PubMed ID: 16055145
[TBL] [Abstract][Full Text] [Related]
22. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry.
McClain MT; Heinlen LD; Dennis GJ; Roebuck J; Harley JB; James JA
Nat Med; 2005 Jan; 11(1):85-9. PubMed ID: 15619631
[TBL] [Abstract][Full Text] [Related]
23. Studies of human polyclonal and monoclonal antibodies binding to lupus autoantigens and cross-reactive antigens.
Sharma A; Isenberg D; Diamond B
Rheumatology (Oxford); 2003 Mar; 42(3):453-63. PubMed ID: 12626796
[TBL] [Abstract][Full Text] [Related]
24. IgG antibodies from patients with primary Sjögren's syndrome and systemic lupus erythematosus recognize different epitopes in 60-kD SSA/Ro protein.
Barakat S; Meyer O; Torterotot F; Youinou P; Briand JP; Kahn MF; Muller S
Clin Exp Immunol; 1992 Jul; 89(1):38-45. PubMed ID: 1378364
[TBL] [Abstract][Full Text] [Related]
25. DNA mimics a self-protein that may be a target for some anti-DNA antibodies in systemic lupus erythematosus.
Zack DJ; Yamamoto K; Wong AL; Stempniak M; French C; Weisbart RH
J Immunol; 1995 Feb; 154(4):1987-94. PubMed ID: 7836777
[TBL] [Abstract][Full Text] [Related]
26. Detection of catalase as a major protein target of the lipid peroxidation product 4-HNE and the lack of its genetic association as a risk factor in SLE.
D'souza A; Kurien BT; Rodgers R; Shenoi J; Kurono S; Matsumoto H; Hensley K; Nath SK; Scofield RH
BMC Med Genet; 2008 Jul; 9():62. PubMed ID: 18606005
[TBL] [Abstract][Full Text] [Related]
27. Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus.
Wirestam L; Schierbeck H; Skogh T; Gunnarsson I; Ottosson L; Erlandsson-Harris H; Wetterö J; Sjöwall C
Arthritis Res Ther; 2015 Nov; 17():338. PubMed ID: 26596890
[TBL] [Abstract][Full Text] [Related]
28. Development of a novel monoclonal antibody against 4-hydroxy-2E,6Z-dodecadienal (4-HDDE)-protein adducts: Immunochemical application in quantitative and qualitative analyses of lipid peroxidation in vitro and ex vivo.
Uchida K; Shibata T; Toyokuni S; Daniel B; Zarkovic K; Zarkovic N; Sasson S
Free Radic Biol Med; 2018 Aug; 124():12-20. PubMed ID: 29807161
[TBL] [Abstract][Full Text] [Related]
29. Oxidatively modified autoantigens in autoimmune diseases.
Kurien BT; Hensley K; Bachmann M; Scofield RH
Free Radic Biol Med; 2006 Aug; 41(4):549-56. PubMed ID: 16863987
[TBL] [Abstract][Full Text] [Related]
30. Autoimmunity and oxidatively modified autoantigens.
Kurien BT; Scofield RH
Autoimmun Rev; 2008 Jul; 7(7):567-73. PubMed ID: 18625446
[TBL] [Abstract][Full Text] [Related]
31. A single-stranded DNA-cross-reactive immunogenic epitope of human homocysteine-inducible endoplasmic reticulum protein.
Oka Y; Hirabayashi Y; Ikeda T; Fujii H; Ishii T; Harigae H
Scand J Immunol; 2011 Sep; 74(3):296-303. PubMed ID: 21535081
[TBL] [Abstract][Full Text] [Related]
32. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations.
Frostegård J; Svenungsson E; Wu R; Gunnarsson I; Lundberg IE; Klareskog L; Hörkkö S; Witztum JL
Arthritis Rheum; 2005 Jan; 52(1):192-200. PubMed ID: 15641060
[TBL] [Abstract][Full Text] [Related]
33. [The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases].
Quattrocchi P; Barrile A; Bonanno D; Giannetto L; Patafi M; Tigano V; Ferlazzo B
Reumatismo; 2005; 57(2):109-13. PubMed ID: 15983634
[TBL] [Abstract][Full Text] [Related]
34. The endoplasmic reticulum stress-inducible protein, Herp, is a potential triggering antigen for anti-DNA response.
Hirabayashi Y; Oka Y; Ikeda T; Fujii H; Ishii T; Sasaki T; Harigae H
J Immunol; 2010 Mar; 184(6):3276-83. PubMed ID: 20147634
[TBL] [Abstract][Full Text] [Related]
35. Immunization with a peptide surrogate for double-stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition.
Putterman C; Diamond B
J Exp Med; 1998 Jul; 188(1):29-38. PubMed ID: 9653081
[TBL] [Abstract][Full Text] [Related]
36. Antibody reactivity to mycobacterial 65 kDa heat shock protein: relevance to autoimmunity.
Karopoulos C; Rowley MJ; Handley CJ; Strugnell RA
J Autoimmun; 1995 Apr; 8(2):235-48. PubMed ID: 7542003
[TBL] [Abstract][Full Text] [Related]
37. Neuronal BC RNA Transport Impairments Caused by Systemic Lupus Erythematosus Autoantibodies.
Muslimov IA; Iacoangeli A; Eom T; Ruiz A; Lee M; Stephenson S; Ginzler EM; Tiedge H
J Neurosci; 2019 Sep; 39(39):7759-7777. PubMed ID: 31405929
[TBL] [Abstract][Full Text] [Related]
38. A potential trigger of nephritogenic anti-DNA antibodies in lupus nephritis.
Hirabayashi Y; Oka Y; Tada M; Takahashi R; Ishii T
Ann N Y Acad Sci; 2007 Jun; 1108():92-5. PubMed ID: 17893974
[TBL] [Abstract][Full Text] [Related]
39. Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis.
Jaekell HP; Trabandt A; Grobe N; Werle E
Lupus; 2006; 15(6):335-45. PubMed ID: 16830879
[TBL] [Abstract][Full Text] [Related]
40. Soluble MHC class II-driven therapy for a systemic lupus erythematosus murine experimental in vitro and in vivo model.
Bakela K; Dimakopoulou M; Batsou P; Manidakis N; Athanassakis I
Scand J Immunol; 2018 Mar; 87(3):. PubMed ID: 29412476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
